EGFR P-LOOP AND ALPHA C-HELIX COMPRESSING

Clinical trials for EGFR P-LOOP AND ALPHA C-HELIX COMPRESSING explained in plain language.

Never miss a new study

Get alerted when new EGFR P-LOOP AND ALPHA C-HELIX COMPRESSING trials appear

Sign up with your email to follow new studies for EGFR P-LOOP AND ALPHA C-HELIX COMPRESSING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Global race for better lung cancer treatment targets rare mutations

Disease control Recruiting now

This global Phase 3 trial is comparing a new drug called firmonertinib against two existing standard treatments for people with advanced non-small cell lung cancer that has specific, less common EGFR genetic mutations. The study aims to see if firmonertinib can better control the…

Matched conditions: EGFR P-LOOP AND ALPHA C-HELIX COMPRESSING

Phase: PHASE3 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

EGFR P-LOOP AND ALPHA C-HELIX COMPRESSING

Get alerted when new EGFR P-LOOP AND ALPHA C-HELIX COMPRESSING trials appear

Global race for better lung cancer treatment targets rare mutations